Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs
- PMID: 15688675
Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs
Abstract
Both beta-adrenergic receptor antagonist drugs (beta-blockers) and non-dihydropyridine calcium-channel blockers (non-DHP CCBs), ie, diltiazem and verapamil, can cause sinus arrest or severe sinus bradycardia, and when drugs from the two classes are used together, these effects may be more than additive. We report nine patients in whom a beta-blocker (one patient), a non-DHP CCB (one patient), or the combination (seven patients) caused sinus arrest or severe sinus bradycardia which resulted in hospitalization in six of the nine. Although this combination of drugs always has the potential for causing profound bradycardia, certain aspects of the history, such as age, the presence of renal or hepatic disease, and the number and types of other medications, are further predictors of marked bradycardia with hypotension.
Similar articles
-
[Combination of slow-release diltiazem and a beta-blocker in arterial hypertension. 2 cases of cardiogenic shock with severe bradycardia].Therapie. 1990 Sep-Oct;45(5):411-3. Therapie. 1990. PMID: 1979694 French.
-
[Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].Ter Arkh. 2006;78(8):30-8. Ter Arkh. 2006. PMID: 17078214 Russian.
-
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.J Am Coll Cardiol. 2004 Jul 7;44(1):105-8. doi: 10.1016/j.jacc.2004.03.057. J Am Coll Cardiol. 2004. PMID: 15234417
-
Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy.J Cardiovasc Pharmacol. 1985;7 Suppl 4:S38-44. doi: 10.1097/00005344-198507004-00008. J Cardiovasc Pharmacol. 1985. PMID: 2412010 Review.
-
Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases.Blood Press. 1996 Sep;5(5):260-3. doi: 10.3109/08037059609078057. Blood Press. 1996. PMID: 8879597 Review.
Cited by
-
Management Protocols of stable coronary artery disease in India: Executive summary.Indian Heart J. 2016 Nov-Dec;68(6):868-873. doi: 10.1016/j.ihj.2016.11.318. Indian Heart J. 2016. PMID: 27931562 Free PMC article. Review. No abstract available.
-
Heart insufficiency after combination of verapamil and metoprolol: A fatal case report and literature review.Clin Case Rep. 2019 Sep 19;7(11):2042-2048. doi: 10.1002/ccr3.2393. eCollection 2019 Nov. Clin Case Rep. 2019. PMID: 31788248 Free PMC article.
-
Management standards for stable coronary artery disease in India.Indian Heart J. 2016 Dec;68 Suppl 3(Suppl 3):S31-S49. doi: 10.1016/j.ihj.2016.11.320. Epub 2016 Dec 9. Indian Heart J. 2016. PMID: 28038722 Free PMC article. Review.
-
Slow group beating.Proc (Bayl Univ Med Cent). 2013 Oct;26(4):407. doi: 10.1080/08998280.2013.11929020. Proc (Bayl Univ Med Cent). 2013. PMID: 24082422 Free PMC article. No abstract available.
-
Adverse effects using combined rate-slowing antihypertensive agents.J Clin Hypertens (Greenwich). 2011 Jul;13(7):529-32. doi: 10.1111/j.1751-7176.2011.00486.x. Epub 2011 Jun 20. J Clin Hypertens (Greenwich). 2011. PMID: 21762367 Free PMC article. No abstract available.